Phase I study of bryostatin-1 in combination with cisplatin in treating patients with metastatic or unresectable solid tumors including non small-cell lung cancer. (Record no. 14459414)

MARC details
000 -LEADER
fixed length control field 00866 a2200229 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250514165731.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200401s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1525-7304
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.3816/clc.1999.n.013
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Lenz, H J
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20040122
245 00 - TITLE STATEMENT
Title Phase I study of bryostatin-1 in combination with cisplatin in treating patients with metastatic or unresectable solid tumors including non small-cell lung cancer.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Clinical lung cancer
Date of publication, distribution, etc. Nov 1999
300 ## - PHYSICAL DESCRIPTION
Extent 151-2 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Raghavan, D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Doroshow, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gandara, D R
773 0# - HOST ITEM ENTRY
Title Clinical lung cancer
Related parts vol. 1
-- no. 2
-- p. 151-2
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.3816/clc.1999.n.013">https://doi.org/10.3816/clc.1999.n.013</a>
Public note Available from publisher's website

No items available.